One such endogenous ‘barrier’ relevant to FUS proteinopathy may be the sequence differences between mouse and human FUS (which differ in 26 out of 526 amino acids), fifteen of which are located in the G-rich, prion-like domain believed to be a major factor in driving aggregation (Fig. S8) [79]. The gene discussed is FUS; the disease is proteostasis deficiencies.